Evidence map›Paper›PMID 40823307›Full record

ArticleFrontiers in neurology2025

Decomposing door-to-needle time: insights into workflow delays and quality improvement in acute stroke care.

Lianyan Wei, Hongfei Li, Zhuangzhuang Jiang, Dongjuan Xu, Xiaolan Wu

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lianyan WeiDepartment of Neurology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Hongfei LiDepartment of Neurology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Zhuangzhuang JiangDepartment of Neurology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Dongjuan XuDepartment of Neurology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Xiaolan WuDepartment of Neurology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Timely administration of intravenous recombinant tissue plasminogen activator (rtPA) significantly improves outcomes in acute ischemic stroke (AIS). However, substantial variability in door-to-needle (DTN) time persists in real-world settings. This study aimed to deconstruct DTN time into distinct workflow intervals to identify key determinants of delay and inform targeted quality improvement. Methods: This retrospective study included 322 consecutive AIS patients treated with intravenous rtPA at Dongyang People's Hospital between May 2023 and April 2025. DTN time was divided into four intervals: door-to-order time (ODT), order-to-imaging completion time (OCT), imaging completion-to-consent time (ICT), and consent-to-needle time (CNT). Real-time data were collected through beacon-based tracking and a time-tracking application. Linear regression, correlation, and subgroup analyses were used to explore factors associated with each interval and overall DTN time. Results: Among all intervals, ICT showed the strongest correlation with DTN time ( Conclusion: Physician seniority, thrombolysis strategy, and MRI-negative status significantly influence DTN time. Segmenting DTN time enables precise identification of key delays across different workflow stages and may enhance the efficiency of acute stroke care.

Indexed as

acute ischemic strokedoor-to-needle timeintravenous thrombolysisphysician experienceworkflow optimization

Identifiers

PMID40823307
PMCPMC12354476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.